Table 3 Association between baseline B-cell activation biomarkers and immunological features of the 578 patients with early rheumatoid arthritis

0.7 (0.5–0.9)

0.7 (0.5–1.0)

0.18

0.7 (0.5–0.9)

0.7 (0.5–0.9)

0.18

2.1 (1.8–2.4)

1.9 (1.6–2.3)

0.01

2.0 (1.7–2.4)

1.9 (1.6–2.4)

0.30

14.0 (12.0–16.9)

13.0 (11.1–15.1)

<10^-4

14.4 (12.4–17.1)

12.9 (11.1–15.9)

<10^-4

2.9 (2.1–3.7)

2.5 (1.9–3.3)

<10^-4

3.1 (2.3–3.8)

2.4 (1.8–3.2)

<10^-4

1.6 (1.2–2.2)

1.3 (1.1–1.8)

<10^-4

1.6 (1.2–2.3)

1.4 (1.0–1.9)

<10^-4

15.8 (12.2–20.6)

12.7 (9.5–16.8)

<10^-4

16.3 (12.7–20.6)

12.7 (9.7–17.1)

<10^-4

18.6 (14.4–25.0)

15.0 (11.8–19.6.)

<10^-4

19.3(14.9–24.9)

15.1 (11.9–19.9)

<10^-4